-
An analysis presented at the 2010 National STD Prevention Conference gives a chilling look at impact of HIV and syphilis among U.S. gay and bisexual men.
-
Several descriptive phrases are now being coined when family planning providers discuss such highly effective reversible methods as intrauterine contraception (ParaGard Copper T 380A intrauterine device, Duramed Pharmaceuticals, and the Mirena levonorgestrel intrauterine system, Bayer HealthCare Pharmaceuticals) and the contraceptive implant (Implanon, Schering-Plough Corp.).
-
-
With drug manufacturers retreating in recent years from voluntary discounts to family planning and other public clinics, providers increasingly rely on federally mandated discounts.
-
-
[This is the second part of a two-part series on electronic media resources. Last month we discussed the California STD/HIV Prevention Training Center's Youth Social Marketing Toolkit.]
-
While you might provide correct information to your adolescent patients when it comes to teen sexual health topics, results of a recent study indicate many popular health web sites do not.
-
Research recently conducted in the area around El Paso, TX, and Juarez, Mexico, suggests there is demand in the United States for over-the-counter birth control pills.
-
While surgery is the most accepted method for treating ovarian endometriomas, recurrence often is recorded. Results from newly published research, which evaluates use of cyclic and continuous administration of oral contraceptives post surgical removal, indicate that Pill use can effectively reduce and delay endometrioma recurrence.
-
Signs have been pointing toward a renaissance for intrauterine devices (IUDs). Since 2005, IUD use has gone up by 161%, according to SDI Health, a health care analytics firm in Plymouth Meeting, PA.